The rapid expansion of Acinetobacter baumannii clinical isolates exhibiting resistance to
carbapenems and most or all available antibiotics during the last decade is a worrying …

Acinetobacter baumannii infections have become an emerging health concern in hospitals
across the world and are often associated with nosocomial infections with poorer clinical …

Background. Extensively drug-resistant (XDR) Acinetobacter baumannii may cause serious
infections in critically ill patients. Colistin often remains the only therapeutic option. Addition …

Chronic wound infections are associated with biofilm formation, which in turn has been
correlated with drug resistance. However, the mechanism by which bacteria form biofilms in …

Acinetobacter baumannii is an opportunistic pathogen that is a cause of clinically significant
nosocomial infections. Increasingly, clinical isolates of A. baumannii are extensively …

Background Acinetobacter baumannii is responsible for large epidemics in hospitals, where
it can persist for long time on abiotic surfaces. This study investigated some virulence …

Multidrug-resistant (MDR) bacteria have become a severe threat to community wellbeing.
Conventional antibiotics are getting progressively more ineffective as a consequence of …

Background Colistin-resistant/carbapenem-resistant Acinetobacter baumannii is a
significant challenge for antibiotic treatment and infection control policies. Since 2012, in …

The quantification, efficiency, and possible mechanisms of mercury phytoremediation by
endophytic bacteria are poorly understood. Here we selected 8 out of 34 previously isolated …

Abstract Background Infections caused by Acinetobacter baumannii were responsive to
conventional antibiotic therapy. However, recently, carbapenem-associated multidrug …